Strta Skn Scnces (SSKN)


Focuses on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The company's flagship product, MelaFind, features a hand-held imaging device.

View SEC Filings from SSKN instead.
Filers who had this stock in their top 10: 0
13F Filers holding this stock: 28
Aggregate shares on 09/30/2016: 2,632,222
Aggregate shares on 06/30/2016: 2,596,269
Percent change: 1.38%
Funds creating new positions: 3
Funds Adding to an existing position: 6
Funds closing out their position: 1
Funds reducing their position: 5
View recent insider trading info

13F Filers holding this stock

Quarter 1: Refresh

Changes in Holdings:

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Schedule 13D and 13G filings submitted since 09/30/2016

Subscription required

Click here to report any possible errors with this stock listing.

Elevate your investments

or Learn more